Skip to main content
Equibles

MetLife Investment Management, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$650,934
+$213,039 QoQ
Shares Held
35,746
+16.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. CGEM ranks #109 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $650,934 35,746
2026-03-31 $437,895 30,816
2025-12-31 $318,945 30,816
2025-09-30 $137,842 23,245
2025-06-30 $236,848 31,454
2025-03-31 $238,106 31,454
2024-12-31 $390,466 32,058
2024-09-30 $499,538 29,841
2024-06-30 $396,341 22,726
2024-03-31 $227,262 13,337
2023-12-31 $135,904 13,337
2023-09-30 $120,699 13,337
2023-06-30 $143,506 13,337
2023-03-31 $168,027 16,425
2022-12-31 $173,283 16,425
2022-09-30 $254,976 19,889
2022-06-30 $197,402 15,398
2022-03-31 $161,217 15,398
2021-12-31 $151,337 9,808
2021-09-30 $221,366 9,808
2021-06-30 $157,023 6,098
2021-03-31 $254,103 6,098